Urology · Jackson, MS
NPI
1144532391
Since 2010
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1421 N State St, Ste 403
Jackson, MS, 39202
Phone (601) 353-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$524K
24,951 services
Medicare patients, 2024
1,203
Average age 75
Drug cost, 2024
$2.1M
4,036 prescriptions
Company payments, 2025
$1,687
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Runnels was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 15,488 times for 160 patients. In total Mark Runnels billed 24,951 services in 121 codes, and Medicare paid $524K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 15,488 | 160 | $0.10 | $1,518 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,040 | 15 | $2.17 | $4,418 |
| 36415 Venipuncture Blood Collection | Office | 1,013 | 764 | $8.54 | $8,650 |
| 99213 Office E&M - Established | Office | 985 | 741 | $62.07 | $61K |
| 84153 Clinical Chemistry | Office | 844 | 649 | $17.83 | $15K |
| 81001 Clinical Chemistry | Office | 672 | 526 | $3.08 | $2,067 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 588 | 72 | $138.42 | $81K |
| 99214 Office E&M - Established | Office | 264 | 245 | $80.39 | $21K |
| 52000 Cystourethroscopy | Facility | 247 | 207 | $59.92 | $15K |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 195 | 14 | $34.39 | $6,706 |
| 82565 Clinical Chemistry | Office | 166 | 163 | $4.90 | $813 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 159 | 139 | $71.90 | $11K |
| 74178 CT/CTA - Abdomen and Pelvis | Office | 109 | 108 | $177.59 | $19K |
| 51798 Ultrasound - Nonspecific | Office | 108 | 93 | $7.60 | $821 |
| 96402 Chemotherapy Administration | Office | 104 | 74 | $22.92 | $2,384 |
By year: 2022 $443K for 18,037 services; 2023 $432K for 20,625 services; 2024 $524K for 24,951 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,013 | 764 | $8.54 | $8,650 |
| 84153 Clinical Chemistry | 844 | 649 | $17.83 | $15K |
| 81001 Clinical Chemistry | 672 | 526 | $3.08 | $2,067 |
| 87798 Infectious Agent Detection by DNA/RNA | 195 | 14 | $34.39 | $6,706 |
| 82565 Clinical Chemistry | 166 | 163 | $4.90 | $813 |
| 87481 Infectious Agent Detection by DNA/RNA | 75 | 14 | $34.39 | $2,579 |
| 87801 Infectious Agent Detection by DNA/RNA | 42 | 13 | $68.80 | $2,889 |
| 87500 Infectious Agent Detection by DNA/RNA | 15 | 14 | $34.39 | $516 |
| 87641 Infectious Agent Detection by DNA/RNA | 15 | 14 | $34.39 | $516 |
| 87651 Infectious Agent Detection by DNA/RNA | 15 | 14 | $34.39 | $516 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Runnels prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,274 prescriptions and refills. In total Mark Runnels wrote 4,036 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,274 | 3,230 | 442 | $17K |
| Dutasteride Generic | 543 | 1,144 | 149 | $17K |
| Finasteride Generic | 295 | 796 | 86 | $3,190 |
| Levofloxacin Generic | 177 | 178 | 160 | $734 |
| Ciprofloxacin Hcl Generic | 167 | 167 | 150 | $767 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 160 | 327 | 44 | $2,418 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 127 | 127 | 117 | $800 |
| Oxybutynin Chloride Generic | 117 | 182 | 50 | $2,096 |
| Gemtesa Vibegron | 90 | 122 | 28 | $57K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 87 | 121 | 30 | $2,720 |
| Erleada Apalutamide | 67 | 67 | Under 11 | $958K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 63 | 71 | 50 | $156 |
| Xtandi Enzalutamide | 53 | 53 | Under 11 | $703K |
| Cefuroxime Cefuroxime Axetil | 53 | 53 | 47 | $788 |
| Myrbetriq Mirabegron | 43 | 59 | 13 | $25K |
Brand drugs: 332 claims; generic drugs: 3,704 claims; opioid claims: 140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Runnels $1,687 ($1,687 in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Biotech, Inc. with $433.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 14 | $433 |
| Sumitomo Pharma America, Inc. 4506.T | 13 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $136 |
| Dendreon Pharmaceuticals LLC | 4 | $93.24 |
| C. R. Bard, Inc. & Subsidiaries BDX | 4 | $73.14 |
| Pfizer Inc. PFE | 3 | $67.69 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $59.38 |
| Merck Sharp & Dohme LLC MRK | 3 | $53.91 |
| Astellas Pharma US Inc 4503.T | 2 | $52.14 |
| Ferring Pharmaceuticals Inc. | 3 | $50.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.